Transgenic Group Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	2,212	2,555	2,478	3,459	4,618	3,030
Short-Term Investments	-	-	-	-	5	-
Cash & Short-Term Investments	2,212	2,555	2,478	3,459	4,623	3,030
Cash Growth	-2.38%	3.11%	-28.36%	-25.18%	52.57%	68.05%
Receivables	1,212	1,211	1,336	1,076	893	1,138
Inventory	2,737	2,221	2,227	2,238	1,714	1,308
Other Current Assets	628	711	508	789	479	335
Total Current Assets	6,789	6,698	6,549	7,562	7,709	5,811
Property, Plant & Equipment	2,037	2,055	2,142	1,991	1,992	2,125
Long-Term Investments	280	246	264	230	234	306
Goodwill	508	531	512	557	365	521
Other Intangible Assets	26	22	21	10	12	12
Long-Term Deferred Tax Assets	-	31	321	320	126	141
Other Long-Term Assets	2	2	-	1	2	2
Total Assets	9,642	9,586	9,810	10,672	10,440	8,918
Accounts Payable	440	413	276	408	256	340
Accrued Expenses	63	69	71	23	16	12
Short-Term Debt	1,075	680	448	170	390	100
Current Portion of Long-Term Debt	630	538	466	492	337	246
Current Portion of Leases	-	-	15	17	16	17
Current Income Taxes Payable	270	275	282	341	724	659
Other Current Liabilities	1,054	1,297	876	1,292	920	790
Total Current Liabilities	3,532	3,272	2,434	2,743	2,659	2,164
Long-Term Debt	1,155	1,356	1,307	1,706	1,031	1,570
Long-Term Leases	-	-	19	31	44	60
Pension & Post-Retirement Benefits	67	68	37	40	24	25
Long-Term Deferred Tax Liabilities	-	12	-	-	-	-
Other Long-Term Liabilities	29	23	16	31	47	63
Total Liabilities	4,783	4,731	3,813	4,551	3,805	3,882
Common Stock	50	50	50	50	50	50
Additional Paid-In Capital	3,856	3,857	3,861	3,869	4,109	4,109
Retained Earnings	957	927	2,067	2,147	2,657	843
Treasury Stock	-116	-116	-135	-76	-300	-1
Comprehensive Income & Other	52	44	50	27	15	-85
Total Common Equity	4,799	4,762	5,893	6,017	6,531	4,916
Minority Interest	60	93	104	104	104	120
Shareholders' Equity	4,859	4,855	5,997	6,121	6,635	5,036
Total Liabilities & Equity	9,642	9,586	9,810	10,672	10,440	8,918
Total Debt	2,860	2,574	2,255	2,416	1,818	1,993
Net Cash (Debt)	-648	-19	223	1,043	2,805	1,037
Net Cash Growth	-	-	-78.62%	-62.82%	170.49%	2862.86%
Net Cash Per Share	-38.91	-1.14	13.27	61.92	163.41	59.70
Filing Date Shares Outstanding	16.65	16.65	16.59	16.86	16.82	17.37
Total Common Shares Outstanding	16.65	16.65	16.59	16.86	16.82	17.37
Working Capital	3,257	3,426	4,115	4,819	5,050	3,647
Book Value Per Share	288.17	285.95	355.13	356.93	388.34	283.05
Tangible Book Value	4,265	4,209	5,360	5,450	6,154	4,383
Tangible Book Value Per Share	256.11	252.74	323.01	323.29	365.92	252.36
Order Backlog	-	3,001	1,956	2,791	2,581	1,734

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.